Answers are grounded in this paper and cite their sources.
Background MSTO1 -related disease (previously termed mitochondrial myopathy with ataxia, MMYAT) is a rare autosomal recessive neurometabolic disorder caused by biallelic pathogenic MSTO1 variants. MSTO1 dysfunction impairs mitochondrial dynamics, leading to skeletal muscle lesions and variable cerebellar involvement. Diagnosis is often delayed due to its rarity and phenotypic heterogeneity. Case Presentation We report an 8-year-old male child presenting with progressive motor impairment and ataxia as the core manifestations, accompanied by bulbar dysfunction. The disease had insidious onset with a slowly progressive clinical course over 6 years. Physical examination revealed decreased limb muscle strength. Brain MRI demonstrated cerebellar atrophy and muscle MRI showed prominent fatty replacement in the bilateral quadriceps and hamstrings. Electromyography revealed myopathic changes. Gene sequencing identified compound heterozygous variants in MSTO1 : NM_018116.3:c.36G>T (p (Gln12His), novel) and NM_018116.3:c.971C>T (p (Thr324Ile), previously reported). Parental Sanger sequencing confirmed that the two variants were located in trans . During follow-up, the patient received empirical supportive medical management. Conclusion We describe a pediatric case of MSTO1 -related disease carrying compound heterozygous variants and summarize the clinical, neuroimaging and genetic characteristics of published MSTO1 -related patients. Clinicians should raise awareness of this rare disorder among children with progressive movement disorders and cerebellar atrophy, to achieve timely diagnosis and optimized supportive care.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: